Daily Bulletin

The Times Real Estate

.

  • Written by PR Newswire Asia - Daily Bulletin Au RSS

SYDNEY, April 8, 2024 /PRNewswire/ -- In a historic first, Cure Brain Cancer Foundation proudly unveiled the launch of its groundbreaking 5-Year Guardian Trust Early Career Fellowship, valued at $575,000.

The Guardian Trust Early Career Fellowship represents a bold commitment to fostering a new generation of leaders in brain cancer research. By providing comprehensive support over a five-year period, Cure Brain Cancer Foundation is empowering young researchers to pursue ideas that challenge the norm and help pioneer breakthroughs that will redefine the fight against brain cancer.

"Innovation in a field such as brain cancer only thrives when you nurture talent and provide opportunities," remarked Lance Kawaguchi, CEO of Cure Brain Cancer Foundation. "Following the successful launch of GBM AGILE in 2023, the Foundation is proud to demonstrate its commitment to pioneering solutions that accelerate progress in the field."

Dr. Hamza Anwer, Head of Research at Cure Brain Cancer Foundation, emphasized the critical importance of attracting talent in a rare cancer field and providing stability to focus on the research. "Brain cancer research requires a relentless pursuit of excellence and innovation. By attracting bright young minds through initiatives like the first ever 5-Year Guardian Trust Early Career Fellowship, we are not only expanding our research capacity but also fostering a supportive environment where researchers can thrive and make meaningful contributions to this challenging field."

Applications for the Guardian Trust Early Career Fellowship open on the 22nd of April 2024.

View Cure Brain Cancer Foundation's website for T&C's and more information: https://www.curebraincancer.org.au/research/for-researchers/funding-opportunities-2024.

About Cure Brain Cancer Foundation  Cure Brain Cancer Foundation (CBCF) is a non-profit organization and Australia's leading brain cancer charity. CBCF is the leading organisation for brain cancer research, advocacy and awareness in Australia, with a mission to rapidly improve brain cancer survival and quality of life and vision to ultimately find a cure for brain cancer. Over the last decade, CBCF has invested over $30 million into clinical trials and pre-clinical efforts across pediatric and adult brain cancers. This includes, over the last 3 years, investing $2 million AUD in world's largest brain cancer-dedicated Clinical Accelerator program to help bring therapies from the bench to the bedside; and over $1.4 million in Fellowships to support researchers on the ground. Cure Brain Cancer Foundation was also the first Australian charity to ring the NASDAQ bell twice within the last 2 years and it successfully fostered the opening of the revolutionary GBM AGILE clinical trial in Australia.

Authors: PR Newswire Asia - Daily Bulletin Au RSS

Read more https://www.prnasia.com/story/archive/4381348_AE81348_0

Business News

How to Estimate the Right Skip Bin Size for Your Renovation Project

One of the most challenging aspects of planning a renovation project is estimating the amount of waste you'll generate. Choosing a skip bin that's too small means paying for additional bins or picku...

Daily Bulletin - avatar Daily Bulletin

Cool Room Hire: The Ultimate Solution for Temperature-Sensitive Storage

Businesses in the food, pharmaceutical, and event industries often require reliable refrigeration to keep products fresh and safe. Cool room hire provides a flexible and cost-effective solution for ...

Daily Bulletin - avatar Daily Bulletin

Thryv Australia named global winner of the 2025 Microsoft Advertising Partner Awards

Melbourne – 11 March 2025:   Thryv® (NASDAQ: THRY), provider of the leading small business marketing and sales software platform, has been named the global winner of the Microsoft Advertising Part...

Daily Bulletin - avatar Daily Bulletin

LayBy Deals